Clinical Trials
12
Active:6
Completed:2
Trial Phases
1 Phases
Phase 2:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 2
6 (100.0%)Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke
Phase 2
Completed
- Conditions
- Ischemic Stroke
- Interventions
- Drug: placeboDrug: SA4503 LowDrug: SA4503 High
- First Posted Date
- 2008-03-20
- Last Posted Date
- 2009-07-29
- Lead Sponsor
- M's Science Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT00639249
- Locations
- 🇬🇧
Southern General Hospital, Glasgow, United Kingdom
SA4503 8-Week Study in Major Depressive Disorder (MDD)
Phase 2
Completed
- Conditions
- Depressive Disorder, Major
- Interventions
- Drug: placeboDrug: SA4503 LowDrug: SA4503 High
- First Posted Date
- 2007-10-30
- Last Posted Date
- 2008-12-18
- Lead Sponsor
- M's Science Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT00551109
News
No news found